Average Co-Inventor Count = 4.63
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (16 from 2,079 patents)
2. Other (2 from 832,912 patents)
3. Ortho-Mcneil Pharmaceutical Corp. (2 from 363 patents)
20 patents:
1. 11993614 - Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
2. 11883367 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
3. 11318157 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
4. 11098062 - Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
5. 10898504 - Substituted nucleoside analogues for use as PRMT5 inhibitors
6. 10653711 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
7. 9079896 - Urotensin II receptor antagonists
8. 8759342 - Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists
9. 8633322 - Alkynyl derivatives useful as DPP-1 inhibitors
10. 8552032 - Bicyclic derivatives useful as inhibitors of DPP-1
11. 8536174 - Urotensin II receptor antagonists
12. 8476302 - α-ketoamide derivatives useful endothelial lipase inhibitors
13. 8445514 - Urotensin II receptor antagonists
14. 8193191 - Urotensin II receptor antagonists
15. 8008299 - Urotensin II receptor antagonists